Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 70 entries
View as:

Sitagliptin for Reducing Inflammation and Immune Activation

Phase: N/A Priority: Normal
NCT ID: NCT02513771 Org: User:
Start: 09/30/15 End: 01/10/17 Due: 01/10/18

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01352117 Org: User:
Start: 11/18/11 End: 11/29/18 Due: 11/29/19

Durability of Adherence in Self-Management of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00991302 Org: User:
Start: 01/31/10 End: 01/31/15 Due: 01/31/16

Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT01427738 Org: User:
Start: 06/30/11 End: 01/31/14 Due: 01/31/15

Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women

Phase: N/A Priority: Normal
NCT ID: NCT00100867 Org: User:
Start: 06/30/06 End: 05/31/10 Due: 05/31/11

A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

Phase: N/A Priority: Normal
NCT ID: NCT00096824 Org: User:
Start: 02/28/06 End: 05/31/10 Due: 05/31/11

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Phase: N/A Priority: Normal
NCT ID: NCT01601626 Org: User:
Start: 07/13/13 End: 06/28/17 Due: 06/28/18

Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00865826 Org: User:
Start: 12/31/09 End: 03/31/11 Due: 03/31/12

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

Phase: N/A Priority: Normal
NCT ID: NCT01777997 Org: User:
Start: 04/25/13 End: 02/07/17 Due: 02/07/18

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

Phase: N/A Priority: Normal
NCT ID: NCT00089505 Org: User:
Start: 11/30/06 End: 02/28/11 Due: 02/28/12

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Phase: N/A Priority: Normal
NCT ID: NCT01515813 Org: User:
Start: 11/30/11 End: 12/31/14 Due: 12/31/15

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00118898 Org: User:
Start: 09/30/05 End: 11/30/09 Due: 11/30/10

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People

Phase: N/A Priority: Normal
NCT ID: NCT00959088 Org: User:
Start: 08/31/09 End: 06/30/12 Due: 06/30/13

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

Phase: N/A Priority: Normal
NCT ID: NCT01351025 Org: User:
Start: 04/14/11 End: 05/31/14 Due: 05/31/15

HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

Phase: N/A Priority: Normal
NCT ID: NCT01315353 Org: User:
Start: 04/04/12 End: 02/01/17 Due: 02/01/18

Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers

Phase: N/A Priority: Normal
NCT ID: NCT02706717 Org: User:
Start: 04/30/16 End: 08/28/17 Due: 08/28/18

Chloroquine for Reducing Immune Activation in HIV- Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00819390 Org: User:
Start: 03/31/09 End: 05/31/13 Due: 05/31/14

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03819114 Org: User:
Start: 05/06/19 End: 11/30/20 Due: 11/30/21

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Phase: N/A Priority: Normal
NCT ID: NCT01352715 Org: User:
Start: 03/13/12 End: 10/29/14 Due: 10/29/15

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00357552 Org: User:
Start: 01/31/08 End: 05/31/12 Due: 05/31/13

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Phase: N/A Priority: Normal
NCT ID: NCT00084136 Org: User:
Start: 05/31/05 End: 05/31/10 Due: 05/31/11

Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01029249 Org: User:
Start: 01/31/10 End: 05/31/13 Due: 05/31/14

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

Phase: N/A Priority: Normal
NCT ID: NCT00959413 Org: User:
Start: 09/30/09 End: 09/30/12 Due: 09/30/13

Essentiality of INH in TB Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01589497 Org: User:
Start: 06/30/15 End: 02/10/16 Due: 02/10/17

Pausing Antiretroviral Treatment Under Structured Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT06031272 Org: User:
Start: 05/28/24 End: 04/05/26 Due: 04/05/27